Personalized extended interval dosing of natalizumab in multiple sclerosis: a prospective multicenter trialZ. van Kempen, E. Hoogervorst, N. Kalkers, J. Mostert,B. Lissenberg-Witte,A. de Vries,A. ten Brinke,B. van Oosten,F. Barkhof, M. Wattjes,C. Teunissen,B. Uitdehaag,T. Rispens, J. KillesteinMULTIPLE SCLEROSIS JOURNAL(2019)引用 32|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要